

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.17061429 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.95654179 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.82327017 |
| 4 | vocalization behavior (GO:0071625) | 5.62057958 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.56956393 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.47005596 |
| 7 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.40199028 |
| 8 | * ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.36588248 |
| 9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.29671840 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.25926845 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 5.13114703 |
| 12 | protein localization to synapse (GO:0035418) | 4.83933373 |
| 13 | * glutamate receptor signaling pathway (GO:0007215) | 4.82386495 |
| 14 | exploration behavior (GO:0035640) | 4.82381618 |
| 15 | glutamate secretion (GO:0014047) | 4.74825976 |
| 16 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.74542124 |
| 17 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.73461190 |
| 18 | * synaptic transmission, glutamatergic (GO:0035249) | 4.69325896 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.60608420 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.60423652 |
| 21 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.59835664 |
| 22 | neuronal action potential propagation (GO:0019227) | 4.51653200 |
| 23 | establishment of mitochondrion localization (GO:0051654) | 4.44583726 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 4.38238903 |
| 25 | * neuron-neuron synaptic transmission (GO:0007270) | 4.36725942 |
| 26 | nucleobase catabolic process (GO:0046113) | 4.35481260 |
| 27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.32428549 |
| 28 | positive regulation of synapse maturation (GO:0090129) | 4.28279498 |
| 29 | regulation of synapse structural plasticity (GO:0051823) | 4.27083636 |
| 30 | neurotransmitter secretion (GO:0007269) | 4.26962311 |
| 31 | regulation of synaptic vesicle transport (GO:1902803) | 4.26216995 |
| 32 | gamma-aminobutyric acid transport (GO:0015812) | 4.26132984 |
| 33 | cell migration in hindbrain (GO:0021535) | 4.26069232 |
| 34 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.15643342 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.15614600 |
| 36 | cellular potassium ion homeostasis (GO:0030007) | 4.07076829 |
| 37 | * long-term memory (GO:0007616) | 4.04673090 |
| 38 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.01565406 |
| 39 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.00705902 |
| 40 | dendritic spine morphogenesis (GO:0060997) | 3.93067205 |
| 41 | positive regulation of membrane potential (GO:0045838) | 3.91687309 |
| 42 | regulation of synaptic plasticity (GO:0048167) | 3.91111111 |
| 43 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.89928733 |
| 44 | regulation of postsynaptic membrane potential (GO:0060078) | 3.88081028 |
| 45 | neuron recognition (GO:0008038) | 3.82485531 |
| 46 | response to auditory stimulus (GO:0010996) | 3.81406276 |
| 47 | synapse assembly (GO:0007416) | 3.80389800 |
| 48 | startle response (GO:0001964) | 3.77329845 |
| 49 | transmission of nerve impulse (GO:0019226) | 3.74715909 |
| 50 | sodium ion export (GO:0071436) | 3.74660930 |
| 51 | long-term synaptic potentiation (GO:0060291) | 3.74505823 |
| 52 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.73960237 |
| 53 | proline transport (GO:0015824) | 3.73282193 |
| 54 | layer formation in cerebral cortex (GO:0021819) | 3.70539815 |
| 55 | behavioral defense response (GO:0002209) | 3.70205295 |
| 56 | behavioral fear response (GO:0001662) | 3.70205295 |
| 57 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.57414587 |
| 58 | positive regulation of synapse assembly (GO:0051965) | 3.56247222 |
| 59 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.55208645 |
| 60 | axonal fasciculation (GO:0007413) | 3.53523108 |
| 61 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.52036114 |
| 62 | synaptic vesicle endocytosis (GO:0048488) | 3.50906446 |
| 63 | neurotransmitter transport (GO:0006836) | 3.50670608 |
| 64 | mitochondrion transport along microtubule (GO:0047497) | 3.49799894 |
| 65 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.49799894 |
| 66 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.48462065 |
| 67 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.47042859 |
| 68 | fear response (GO:0042596) | 3.43381718 |
| 69 | neuromuscular process controlling balance (GO:0050885) | 3.42994389 |
| 70 | response to histamine (GO:0034776) | 3.39383516 |
| 71 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.38904223 |
| 72 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.38542451 |
| 73 | cell communication by electrical coupling (GO:0010644) | 3.37554590 |
| 74 | regulation of vesicle fusion (GO:0031338) | 3.37473504 |
| 75 | innervation (GO:0060384) | 3.35129684 |
| 76 | regulation of synapse maturation (GO:0090128) | 3.34737446 |
| 77 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.33572979 |
| 78 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.33469047 |
| 79 | membrane depolarization (GO:0051899) | 3.33063632 |
| 80 | positive regulation of dendritic spine development (GO:0060999) | 3.32604625 |
| 81 | postsynaptic membrane organization (GO:0001941) | 3.32174306 |
| 82 | dendritic spine organization (GO:0097061) | 3.29750535 |
| 83 | membrane depolarization during action potential (GO:0086010) | 3.29299012 |
| 84 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.28622838 |
| 85 | learning (GO:0007612) | 3.28340338 |
| 86 | regulation of neurotransmitter secretion (GO:0046928) | 3.27772598 |
| 87 | regulation of neurotransmitter levels (GO:0001505) | 3.27380664 |
| 88 | activation of protein kinase A activity (GO:0034199) | 3.25098647 |
| 89 | regulation of dendritic spine development (GO:0060998) | 3.24697297 |
| 90 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.22711069 |
| 91 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.22341914 |
| 92 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.20868736 |
| 93 | positive regulation of vascular permeability (GO:0043117) | 3.20263976 |
| 94 | regulation of female receptivity (GO:0045924) | 3.17115048 |
| 95 | cellular sodium ion homeostasis (GO:0006883) | 3.16812327 |
| 96 | presynaptic membrane assembly (GO:0097105) | 3.15002281 |
| 97 | regulation of synaptic transmission (GO:0050804) | 3.14875544 |
| 98 | dendrite morphogenesis (GO:0048813) | 3.13743112 |
| 99 | positive regulation of neurotransmitter transport (GO:0051590) | 3.12290465 |
| 100 | central nervous system neuron axonogenesis (GO:0021955) | 3.11418092 |
| 101 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.11163334 |
| 102 | synapse organization (GO:0050808) | 3.10301408 |
| 103 | long term synaptic depression (GO:0060292) | 3.09955229 |
| 104 | neuromuscular process controlling posture (GO:0050884) | 3.09334688 |
| 105 | vesicle transport along microtubule (GO:0047496) | 3.09263326 |
| 106 | positive regulation of synaptic transmission (GO:0050806) | 3.08708995 |
| 107 | chemosensory behavior (GO:0007635) | 3.07966340 |
| 108 | regulation of neurotransmitter transport (GO:0051588) | 3.07347749 |
| 109 | * synaptic transmission (GO:0007268) | 3.07198188 |
| 110 | neuronal ion channel clustering (GO:0045161) | 3.07092126 |
| 111 | spinal cord development (GO:0021510) | 3.05806694 |
| 112 | cerebellar granule cell differentiation (GO:0021707) | 3.04446582 |
| 113 | limb bud formation (GO:0060174) | 3.02202431 |
| 114 | presynaptic membrane organization (GO:0097090) | 3.02030372 |
| 115 | auditory behavior (GO:0031223) | 3.01352284 |
| 116 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.01153314 |
| 117 | adult walking behavior (GO:0007628) | 3.00718442 |
| 118 | glycosphingolipid biosynthetic process (GO:0006688) | 3.00375310 |
| 119 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.99752244 |
| 120 | L-amino acid import (GO:0043092) | 2.98235565 |
| 121 | regulation of synapse assembly (GO:0051963) | 2.94679050 |
| 122 | amino acid import (GO:0043090) | 2.93658829 |
| 123 | axon extension (GO:0048675) | 2.90414404 |
| 124 | C4-dicarboxylate transport (GO:0015740) | 2.88596133 |
| 125 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.88239210 |
| 126 | negative regulation of dendrite development (GO:2000171) | 2.86066896 |
| 127 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.84150889 |
| 128 | mechanosensory behavior (GO:0007638) | 2.83465426 |
| 129 | axonogenesis (GO:0007409) | 2.79519186 |
| 130 | membrane assembly (GO:0071709) | 2.77596840 |
| 131 | regulation of axon guidance (GO:1902667) | 2.77577422 |
| 132 | dendrite development (GO:0016358) | 2.77161496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.66810755 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.57397863 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.20758902 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.18635694 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.15293871 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.78732204 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.78732204 |
| 8 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.75535583 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.74157614 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.70917696 |
| 11 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.67293671 |
| 12 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.65637364 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.62559833 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.62141219 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.56929623 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.52146920 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50979212 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.47346136 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.40451786 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.36840548 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.26301606 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.25495578 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.22987292 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.20988716 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.08802461 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.01849224 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.84330808 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.77718097 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76342519 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.75223399 |
| 31 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73365304 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.73250169 |
| 33 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.70654427 |
| 34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69780197 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.68168095 |
| 36 | * ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.57708380 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53977298 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.53712145 |
| 39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.49305090 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47081946 |
| 41 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45418903 |
| 42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.42716432 |
| 43 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.39656824 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38401777 |
| 45 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36868213 |
| 46 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32855837 |
| 47 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.32503794 |
| 48 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31364441 |
| 49 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31205862 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29612613 |
| 51 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29583233 |
| 52 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.28914348 |
| 53 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27924815 |
| 54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27801609 |
| 55 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27355633 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23740666 |
| 57 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22865456 |
| 58 | * AR_19668381_ChIP-Seq_PC3_Human | 1.21753053 |
| 59 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19956055 |
| 60 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19089483 |
| 61 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.18539139 |
| 62 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.15818749 |
| 63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15752671 |
| 64 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15642275 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15402974 |
| 66 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14964520 |
| 67 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14394060 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14314451 |
| 69 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14101205 |
| 70 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12392939 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12323356 |
| 72 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12008012 |
| 73 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.11107056 |
| 74 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.10542160 |
| 75 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.09110567 |
| 76 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08784095 |
| 77 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.08531170 |
| 78 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.08518639 |
| 79 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07379897 |
| 80 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06884091 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06884091 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06149159 |
| 83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05623951 |
| 84 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.04888452 |
| 85 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04114730 |
| 86 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.03889823 |
| 87 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.03667322 |
| 88 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03337650 |
| 89 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03196654 |
| 90 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03110934 |
| 91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02021910 |
| 92 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01466592 |
| 93 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00192233 |
| 94 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99820542 |
| 95 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99566981 |
| 96 | FUS_26573619_Chip-Seq_HEK293_Human | 0.98882237 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98455448 |
| 98 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.97982952 |
| 99 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97830035 |
| 100 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97775396 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97581275 |
| 102 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97209556 |
| 103 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96958387 |
| 104 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96909017 |
| 105 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96738938 |
| 106 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96578936 |
| 107 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96137935 |
| 108 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95405842 |
| 109 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94597792 |
| 110 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94295214 |
| 111 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94054740 |
| 112 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.94024673 |
| 113 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93375541 |
| 114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91611735 |
| 115 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91581977 |
| 116 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91580815 |
| 117 | JUN_21703547_ChIP-Seq_K562_Human | 0.90487198 |
| 118 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.90383126 |
| 119 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88905325 |
| 120 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88310049 |
| 121 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88310049 |
| 122 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86783279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0004859_abnormal_synaptic_plasticity | 7.14287692 |
| 2 | MP0003880_abnormal_central_pattern | 5.32746705 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.45774939 |
| 4 | * MP0009745_abnormal_behavioral_response | 3.69329981 |
| 5 | * MP0002063_abnormal_learning/memory/cond | 3.60150510 |
| 6 | MP0004270_analgesia | 3.59561229 |
| 7 | MP0002064_seizures | 3.36720576 |
| 8 | MP0009046_muscle_twitch | 3.10098076 |
| 9 | MP0002822_catalepsy | 2.98438844 |
| 10 | * MP0002572_abnormal_emotion/affect_behav | 2.95724037 |
| 11 | * MP0002272_abnormal_nervous_system | 2.71969425 |
| 12 | * MP0001968_abnormal_touch/_nociception | 2.64766852 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.57741679 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.54244489 |
| 15 | MP0001486_abnormal_startle_reflex | 2.54066161 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.49608561 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.32309812 |
| 18 | MP0008569_lethality_at_weaning | 1.96489205 |
| 19 | * MP0002735_abnormal_chemical_nociception | 1.96000370 |
| 20 | * MP0002067_abnormal_sensory_capabilities | 1.94191656 |
| 21 | MP0002733_abnormal_thermal_nociception | 1.91283857 |
| 22 | MP0003329_amyloid_beta_deposits | 1.89823498 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.87714043 |
| 24 | MP0002184_abnormal_innervation | 1.82637764 |
| 25 | * MP0002736_abnormal_nociception_after | 1.81753491 |
| 26 | MP0003787_abnormal_imprinting | 1.80571833 |
| 27 | * MP0001970_abnormal_pain_threshold | 1.80137866 |
| 28 | MP0000778_abnormal_nervous_system | 1.78833368 |
| 29 | MP0004858_abnormal_nervous_system | 1.74925809 |
| 30 | MP0004811_abnormal_neuron_physiology | 1.74309606 |
| 31 | * MP0002557_abnormal_social/conspecific_i | 1.67094260 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.66430095 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.64533819 |
| 34 | MP0004924_abnormal_behavior | 1.64533819 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.61650950 |
| 36 | MP0004885_abnormal_endolymph | 1.57766568 |
| 37 | MP0003879_abnormal_hair_cell | 1.51713882 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.48272352 |
| 39 | * MP0000955_abnormal_spinal_cord | 1.44128305 |
| 40 | MP0003121_genomic_imprinting | 1.43460924 |
| 41 | * MP0002066_abnormal_motor_capabilities/c | 1.42742658 |
| 42 | * MP0002882_abnormal_neuron_morphology | 1.38307635 |
| 43 | MP0003633_abnormal_nervous_system | 1.37288804 |
| 44 | MP0001984_abnormal_olfaction | 1.34404161 |
| 45 | MP0001529_abnormal_vocalization | 1.30458942 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.26469911 |
| 47 | MP0001188_hyperpigmentation | 1.24634804 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.22789872 |
| 49 | MP0001905_abnormal_dopamine_level | 1.22763809 |
| 50 | MP0004142_abnormal_muscle_tone | 1.21832019 |
| 51 | MP0003631_nervous_system_phenotype | 1.17367614 |
| 52 | MP0002152_abnormal_brain_morphology | 1.10969798 |
| 53 | MP0003122_maternal_imprinting | 1.09063037 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.04723334 |
| 55 | MP0002653_abnormal_ependyma_morphology | 1.03395122 |
| 56 | MP0003075_altered_response_to | 1.03009818 |
| 57 | MP0001177_atelectasis | 0.99022204 |
| 58 | MP0005187_abnormal_penis_morphology | 0.98921917 |
| 59 | MP0000751_myopathy | 0.98828837 |
| 60 | MP0008872_abnormal_physiological_respon | 0.98039469 |
| 61 | MP0002069_abnormal_eating/drinking_beha | 0.96987334 |
| 62 | MP0008874_decreased_physiological_sensi | 0.96918997 |
| 63 | MP0005367_renal/urinary_system_phenotyp | 0.93742133 |
| 64 | MP0000516_abnormal_urinary_system | 0.93742133 |
| 65 | MP0000026_abnormal_inner_ear | 0.93266260 |
| 66 | MP0002229_neurodegeneration | 0.91748077 |
| 67 | MP0001986_abnormal_taste_sensitivity | 0.91713325 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 0.91008423 |
| 69 | MP0001299_abnormal_eye_distance/ | 0.90610312 |
| 70 | MP0002751_abnormal_autonomic_nervous | 0.90234463 |
| 71 | MP0003136_yellow_coat_color | 0.89797221 |
| 72 | MP0004510_myositis | 0.89273917 |
| 73 | MP0000049_abnormal_middle_ear | 0.89116909 |
| 74 | MP0002102_abnormal_ear_morphology | 0.88706765 |
| 75 | MP0003690_abnormal_glial_cell | 0.88211141 |
| 76 | MP0003632_abnormal_nervous_system | 0.86978554 |
| 77 | MP0004215_abnormal_myocardial_fiber | 0.86896026 |
| 78 | MP0004085_abnormal_heartbeat | 0.86417910 |
| 79 | MP0010386_abnormal_urinary_bladder | 0.86331343 |
| 80 | MP0003938_abnormal_ear_development | 0.86114859 |
| 81 | MP0000604_amyloidosis | 0.85156918 |
| 82 | MP0005551_abnormal_eye_electrophysiolog | 0.82763674 |
| 83 | MP0004484_altered_response_of | 0.82428336 |
| 84 | MP0001963_abnormal_hearing_physiology | 0.81605508 |
| 85 | MP0002876_abnormal_thyroid_physiology | 0.81473845 |
| 86 | MP0005535_abnormal_body_temperature | 0.80749659 |
| 87 | MP0005409_darkened_coat_color | 0.79536200 |
| 88 | MP0003385_abnormal_body_wall | 0.79204394 |
| 89 | MP0003634_abnormal_glial_cell | 0.77279017 |
| 90 | MP0005253_abnormal_eye_physiology | 0.76958078 |
| 91 | MP0004742_abnormal_vestibular_system | 0.75626113 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.75246611 |
| 93 | MP0003119_abnormal_digestive_system | 0.74295148 |
| 94 | MP0000920_abnormal_myelination | 0.74031456 |
| 95 | MP0008877_abnormal_DNA_methylation | 0.73132185 |
| 96 | MP0000534_abnormal_ureter_morphology | 0.73065628 |
| 97 | MP0000013_abnormal_adipose_tissue | 0.72684974 |
| 98 | MP0005623_abnormal_meninges_morphology | 0.72044942 |
| 99 | MP0010770_preweaning_lethality | 0.71847067 |
| 100 | MP0002082_postnatal_lethality | 0.71847067 |
| 101 | MP0004133_heterotaxia | 0.71017529 |
| 102 | MP0002081_perinatal_lethality | 0.70983982 |
| 103 | MP0005499_abnormal_olfactory_system | 0.70642793 |
| 104 | MP0005394_taste/olfaction_phenotype | 0.70642793 |
| 105 | MP0002752_abnormal_somatic_nervous | 0.69136157 |
| 106 | MP0010768_mortality/aging | 0.67710292 |
| 107 | MP0003283_abnormal_digestive_organ | 0.67558200 |
| 108 | MP0003137_abnormal_impulse_conducting | 0.67085817 |
| 109 | MP0005248_abnormal_Harderian_gland | 0.65976415 |
| 110 | MP0001485_abnormal_pinna_reflex | 0.65425090 |
| 111 | MP0008961_abnormal_basal_metabolism | 0.63781067 |
| 112 | MP0002233_abnormal_nose_morphology | 0.62924918 |
| 113 | MP0004233_abnormal_muscle_weight | 0.62535635 |
| 114 | MP0006292_abnormal_olfactory_placode | 0.62524295 |
| 115 | MP0003755_abnormal_palate_morphology | 0.62200359 |
| 116 | MP0001664_abnormal_digestion | 0.62065995 |
| 117 | MP0000631_abnormal_neuroendocrine_gland | 0.62013439 |
| 118 | MP0002090_abnormal_vision | 0.61702732 |
| 119 | MP0002638_abnormal_pupillary_reflex | 0.59595033 |
| 120 | MP0000569_abnormal_digit_pigmentation | 0.59274896 |
| 121 | MP0004043_abnormal_pH_regulation | 0.55480731 |
| 122 | MP0010234_abnormal_vibrissa_follicle | 0.54825829 |
| 123 | MP0002234_abnormal_pharynx_morphology | 0.54010760 |
| 124 | MP0003861_abnormal_nervous_system | 0.53203820 |
| 125 | MP0010769_abnormal_survival | 0.52654680 |
| 126 | MP0001943_abnormal_respiration | 0.50600793 |
| 127 | MP0001765_abnormal_ion_homeostasis | 0.50111717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.80099430 |
| 2 | Myokymia (HP:0002411) | 7.40962649 |
| 3 | Focal seizures (HP:0007359) | 6.10917739 |
| 4 | Visual hallucinations (HP:0002367) | 5.52000166 |
| 5 | Atonic seizures (HP:0010819) | 4.94850513 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.93715607 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.89259971 |
| 8 | Febrile seizures (HP:0002373) | 4.88577942 |
| 9 | Absence seizures (HP:0002121) | 4.48611989 |
| 10 | Action tremor (HP:0002345) | 4.22425786 |
| 11 | Dialeptic seizures (HP:0011146) | 4.17681842 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.12678060 |
| 13 | Broad-based gait (HP:0002136) | 3.72994431 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 3.68293470 |
| 15 | Hyperventilation (HP:0002883) | 3.57380396 |
| 16 | Dysdiadochokinesis (HP:0002075) | 3.52780207 |
| 17 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.50266665 |
| 18 | Supranuclear gaze palsy (HP:0000605) | 3.46526737 |
| 19 | Dysmetria (HP:0001310) | 3.46383594 |
| 20 | Limb dystonia (HP:0002451) | 3.41307860 |
| 21 | Abnormality of the lower motor neuron (HP:0002366) | 3.33124318 |
| 22 | Depression (HP:0000716) | 3.31366355 |
| 23 | Poor eye contact (HP:0000817) | 3.31137194 |
| 24 | Truncal ataxia (HP:0002078) | 3.15862987 |
| 25 | Anxiety (HP:0000739) | 3.14971965 |
| 26 | Amblyopia (HP:0000646) | 3.14433563 |
| 27 | Morphological abnormality of the middle ear (HP:0008609) | 3.11196277 |
| 28 | Abnormality of binocular vision (HP:0011514) | 3.05870507 |
| 29 | Diplopia (HP:0000651) | 3.05870507 |
| 30 | Impaired social interactions (HP:0000735) | 3.02594805 |
| 31 | Abnormal social behavior (HP:0012433) | 3.02594805 |
| 32 | Genetic anticipation (HP:0003743) | 3.01993232 |
| 33 | Impaired smooth pursuit (HP:0007772) | 2.99738009 |
| 34 | Abnormal eating behavior (HP:0100738) | 2.99065407 |
| 35 | Hemiparesis (HP:0001269) | 2.98109486 |
| 36 | Postural instability (HP:0002172) | 2.95217781 |
| 37 | Neonatal short-limb short stature (HP:0008921) | 2.93135492 |
| 38 | Scanning speech (HP:0002168) | 2.91556410 |
| 39 | Excessive salivation (HP:0003781) | 2.90058894 |
| 40 | Drooling (HP:0002307) | 2.90058894 |
| 41 | Ankle clonus (HP:0011448) | 2.84731918 |
| 42 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.83853130 |
| 43 | Mutism (HP:0002300) | 2.81238128 |
| 44 | Cerebral inclusion bodies (HP:0100314) | 2.81006179 |
| 45 | Hemiplegia (HP:0002301) | 2.77744902 |
| 46 | Neurofibrillary tangles (HP:0002185) | 2.68587450 |
| 47 | Intention tremor (HP:0002080) | 2.64247239 |
| 48 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.63703463 |
| 49 | Epileptiform EEG discharges (HP:0011182) | 2.58752502 |
| 50 | Progressive inability to walk (HP:0002505) | 2.57863777 |
| 51 | Bradykinesia (HP:0002067) | 2.52809312 |
| 52 | Stereotypic behavior (HP:0000733) | 2.51593211 |
| 53 | Dysmetric saccades (HP:0000641) | 2.48825174 |
| 54 | Focal dystonia (HP:0004373) | 2.44938925 |
| 55 | Torticollis (HP:0000473) | 2.44313226 |
| 56 | Spastic gait (HP:0002064) | 2.43981906 |
| 57 | Urinary urgency (HP:0000012) | 2.41959161 |
| 58 | Absent speech (HP:0001344) | 2.36672305 |
| 59 | Status epilepticus (HP:0002133) | 2.36667963 |
| 60 | Gait imbalance (HP:0002141) | 2.36656340 |
| 61 | Mild short stature (HP:0003502) | 2.34675493 |
| 62 | Annular pancreas (HP:0001734) | 2.34170101 |
| 63 | EEG with generalized epileptiform discharges (HP:0011198) | 2.33604472 |
| 64 | Impaired vibratory sensation (HP:0002495) | 2.33160251 |
| 65 | Ventricular fibrillation (HP:0001663) | 2.31367999 |
| 66 | Papilledema (HP:0001085) | 2.31040301 |
| 67 | Lissencephaly (HP:0001339) | 2.25549252 |
| 68 | Exotropia (HP:0000577) | 2.23671427 |
| 69 | Fetal akinesia sequence (HP:0001989) | 2.22268998 |
| 70 | Megalencephaly (HP:0001355) | 2.20412589 |
| 71 | Pachygyria (HP:0001302) | 2.19330925 |
| 72 | Hypsarrhythmia (HP:0002521) | 2.19307448 |
| 73 | Cortical dysplasia (HP:0002539) | 2.19243628 |
| 74 | Hypoplasia of the corpus callosum (HP:0002079) | 2.16971647 |
| 75 | Abnormality of the labia minora (HP:0012880) | 2.16617258 |
| 76 | Abnormality of the ischium (HP:0003174) | 2.12631364 |
| 77 | Generalized myoclonic seizures (HP:0002123) | 2.12073943 |
| 78 | Split foot (HP:0001839) | 2.08522006 |
| 79 | Amyotrophic lateral sclerosis (HP:0007354) | 2.08064031 |
| 80 | Incomplete penetrance (HP:0003829) | 2.07658928 |
| 81 | Spastic tetraplegia (HP:0002510) | 2.07239563 |
| 82 | Pointed chin (HP:0000307) | 2.06429073 |
| 83 | Abnormality of the corticospinal tract (HP:0002492) | 2.05736296 |
| 84 | Inability to walk (HP:0002540) | 2.04624778 |
| 85 | Craniofacial dystonia (HP:0012179) | 2.04555075 |
| 86 | Hammertoe (HP:0001765) | 2.01732900 |
| 87 | Gait ataxia (HP:0002066) | 2.01547708 |
| 88 | Termporal pattern (HP:0011008) | 2.01545706 |
| 89 | Insidious onset (HP:0003587) | 2.01545706 |
| 90 | Cutaneous finger syndactyly (HP:0010554) | 2.01012524 |
| 91 | Polyphagia (HP:0002591) | 2.00552589 |
| 92 | Peripheral hypomyelination (HP:0007182) | 1.99501510 |
| 93 | Lower limb muscle weakness (HP:0007340) | 1.98222659 |
| 94 | Neuronal loss in central nervous system (HP:0002529) | 1.97763273 |
| 95 | Psychosis (HP:0000709) | 1.96305159 |
| 96 | Specific learning disability (HP:0001328) | 1.95812057 |
| 97 | Esotropia (HP:0000565) | 1.95148750 |
| 98 | Delusions (HP:0000746) | 1.94407287 |
| 99 | Abnormality of salivation (HP:0100755) | 1.94311433 |
| 100 | Lower limb asymmetry (HP:0100559) | 1.94171131 |
| 101 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.92998735 |
| 102 | Hypoplasia of the brainstem (HP:0002365) | 1.92998735 |
| 103 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.91995819 |
| 104 | Hepatoblastoma (HP:0002884) | 1.91965395 |
| 105 | Ulnar claw (HP:0001178) | 1.90458148 |
| 106 | Abnormality of saccadic eye movements (HP:0000570) | 1.86557183 |
| 107 | Blue irides (HP:0000635) | 1.86002651 |
| 108 | Protruding tongue (HP:0010808) | 1.85653175 |
| 109 | Increased circulating renin level (HP:0000848) | 1.84770864 |
| 110 | Agitation (HP:0000713) | 1.84165052 |
| 111 | Obstructive sleep apnea (HP:0002870) | 1.84142429 |
| 112 | Abnormal EKG (HP:0003115) | 1.81411343 |
| 113 | Rapidly progressive (HP:0003678) | 1.80544658 |
| 114 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.79055418 |
| 115 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.79055418 |
| 116 | Oligodactyly (hands) (HP:0001180) | 1.78367137 |
| 117 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.78081203 |
| 118 | Thickened helices (HP:0000391) | 1.76270780 |
| 119 | Vitreoretinal degeneration (HP:0000655) | 1.75784611 |
| 120 | Insomnia (HP:0100785) | 1.75276395 |
| 121 | Bundle branch block (HP:0011710) | 1.74730035 |
| 122 | Rigidity (HP:0002063) | 1.74671380 |
| 123 | Inappropriate behavior (HP:0000719) | 1.72849295 |
| 124 | Pheochromocytoma (HP:0002666) | 1.72672999 |
| 125 | Anosmia (HP:0000458) | 1.71646386 |
| 126 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.71470755 |
| 127 | Neuroendocrine neoplasm (HP:0100634) | 1.70393962 |
| 128 | Optic nerve hypoplasia (HP:0000609) | 1.70167957 |
| 129 | Sleep apnea (HP:0010535) | 1.70123456 |
| 130 | Decreased circulating renin level (HP:0003351) | 1.69163643 |
| 131 | Congenital primary aphakia (HP:0007707) | 1.68849763 |
| 132 | Horizontal nystagmus (HP:0000666) | 1.68703417 |
| 133 | Genital tract atresia (HP:0001827) | 1.68382837 |
| 134 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.68366512 |
| 135 | Failure to thrive in infancy (HP:0001531) | 1.67409202 |
| 136 | Cupped ear (HP:0000378) | 1.67371521 |
| 137 | Cutaneous syndactyly (HP:0012725) | 1.67261206 |
| 138 | Medial flaring of the eyebrow (HP:0010747) | 1.66217702 |
| 139 | Retinal dysplasia (HP:0007973) | 1.65004703 |
| 140 | Renal hypoplasia (HP:0000089) | 1.64065496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.54575101 |
| 2 | NTRK3 | 5.41651896 |
| 3 | MAP3K9 | 3.45674560 |
| 4 | MAP3K4 | 2.94024051 |
| 5 | MINK1 | 2.60310741 |
| 6 | MAP2K7 | 2.53013488 |
| 7 | MARK1 | 2.52199749 |
| 8 | RIPK4 | 2.40065267 |
| 9 | BCR | 2.20628564 |
| 10 | KSR2 | 2.16763013 |
| 11 | DAPK2 | 2.11688421 |
| 12 | NTRK2 | 1.98973861 |
| 13 | PAK6 | 1.97445436 |
| 14 | PRKD3 | 1.90283613 |
| 15 | TNIK | 1.88593061 |
| 16 | MAP2K4 | 1.86107481 |
| 17 | MAP3K12 | 1.85087033 |
| 18 | CAMKK1 | 1.77419711 |
| 19 | KSR1 | 1.76046907 |
| 20 | PRPF4B | 1.71951004 |
| 21 | FES | 1.68331042 |
| 22 | DAPK1 | 1.61730921 |
| 23 | ARAF | 1.60970136 |
| 24 | CASK | 1.58068571 |
| 25 | NTRK1 | 1.57081679 |
| 26 | CDK5 | 1.52046353 |
| 27 | PLK2 | 1.51616531 |
| 28 | MAP3K13 | 1.51513136 |
| 29 | STK38 | 1.44809904 |
| 30 | DYRK2 | 1.43561811 |
| 31 | GRK5 | 1.32417137 |
| 32 | SIK2 | 1.29121730 |
| 33 | PNCK | 1.23589104 |
| 34 | TRIM28 | 1.21415457 |
| 35 | EPHB2 | 1.19929999 |
| 36 | MAPK13 | 1.18947989 |
| 37 | PTK2B | 1.16521872 |
| 38 | * PRKCG | 1.11863630 |
| 39 | MAP3K2 | 1.09642203 |
| 40 | CDK19 | 1.05358247 |
| 41 | * CAMK2A | 1.04799283 |
| 42 | BMPR2 | 1.03391472 |
| 43 | RAF1 | 1.02559972 |
| 44 | CAMK1 | 1.01634642 |
| 45 | CAMKK2 | 0.97206481 |
| 46 | TYRO3 | 0.96910417 |
| 47 | NME1 | 0.95916104 |
| 48 | SGK494 | 0.88691606 |
| 49 | SGK223 | 0.88691606 |
| 50 | SGK2 | 0.84549957 |
| 51 | PINK1 | 0.82605420 |
| 52 | CDK18 | 0.82514219 |
| 53 | * CAMK2B | 0.82463265 |
| 54 | UHMK1 | 0.81237198 |
| 55 | CDK15 | 0.81063556 |
| 56 | FRK | 0.80978747 |
| 57 | MAP4K2 | 0.79259405 |
| 58 | SGK1 | 0.78786377 |
| 59 | CDK14 | 0.76884238 |
| 60 | PRKCH | 0.76810821 |
| 61 | PKN1 | 0.76369037 |
| 62 | PHKG1 | 0.74973054 |
| 63 | PHKG2 | 0.74973054 |
| 64 | FER | 0.74834096 |
| 65 | DYRK1A | 0.73660994 |
| 66 | STK11 | 0.73451146 |
| 67 | MARK2 | 0.70084888 |
| 68 | RIPK1 | 0.69771653 |
| 69 | CDK11A | 0.69651241 |
| 70 | SGK3 | 0.69269223 |
| 71 | PDK1 | 0.68560027 |
| 72 | EPHA3 | 0.66870714 |
| 73 | ERBB3 | 0.64848573 |
| 74 | TAOK1 | 0.64180901 |
| 75 | CSNK1G3 | 0.63968648 |
| 76 | STK38L | 0.63916448 |
| 77 | RPS6KA4 | 0.63905617 |
| 78 | PAK3 | 0.62906501 |
| 79 | RET | 0.62309869 |
| 80 | MAP3K7 | 0.62194220 |
| 81 | TNK2 | 0.62073659 |
| 82 | CSNK1A1L | 0.61536794 |
| 83 | FGR | 0.60773669 |
| 84 | PDPK1 | 0.60017213 |
| 85 | LMTK2 | 0.59406698 |
| 86 | LATS2 | 0.58143942 |
| 87 | OXSR1 | 0.57657218 |
| 88 | ALK | 0.56871721 |
| 89 | PRKCE | 0.56313328 |
| 90 | MAP3K1 | 0.55780884 |
| 91 | CSNK1G1 | 0.53198288 |
| 92 | YES1 | 0.52509385 |
| 93 | NEK6 | 0.50819572 |
| 94 | STK39 | 0.49400645 |
| 95 | CSNK1G2 | 0.49335598 |
| 96 | RPS6KA3 | 0.49158424 |
| 97 | AKT3 | 0.48710762 |
| 98 | BRD4 | 0.47589113 |
| 99 | CSNK1D | 0.47492080 |
| 100 | PRKCZ | 0.47481072 |
| 101 | CAMK4 | 0.46791610 |
| 102 | FYN | 0.46256292 |
| 103 | BRAF | 0.45696780 |
| 104 | MAPK10 | 0.45358472 |
| 105 | ROCK1 | 0.44007691 |
| 106 | MKNK2 | 0.43902518 |
| 107 | CDC42BPA | 0.42910187 |
| 108 | MAP3K6 | 0.42810785 |
| 109 | DMPK | 0.40979030 |
| 110 | PKN2 | 0.39819352 |
| 111 | MAP2K1 | 0.39742715 |
| 112 | ROCK2 | 0.37061214 |
| 113 | CCNB1 | 0.35963416 |
| 114 | WNK1 | 0.34417818 |
| 115 | CSNK1E | 0.33551850 |
| 116 | PRKCB | 0.33476558 |
| 117 | * CAMK2D | 0.33218315 |
| 118 | ERBB2 | 0.32649606 |
| 119 | CDK3 | 0.32403142 |
| 120 | CSNK1A1 | 0.31653513 |
| 121 | PRKACB | 0.31550272 |
| 122 | * PRKCA | 0.31000416 |
| 123 | CAMK1G | 0.30934665 |
| 124 | MAPK8 | 0.30929712 |
| 125 | GSK3B | 0.30157165 |
| 126 | DYRK1B | 0.29113329 |
| 127 | MOS | 0.29055617 |
| 128 | MAPK9 | 0.28893719 |
| 129 | WNK3 | 0.28569524 |
| 130 | FGFR2 | 0.27978069 |
| 131 | * PRKACA | 0.27379556 |
| 132 | PRKG1 | 0.26119074 |
| 133 | TAOK2 | 0.26100503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Nicotine addiction_Homo sapiens_hsa05033 | 4.08303590 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.05402455 |
| 3 | * Long-term potentiation_Homo sapiens_hsa04720 | 2.92447266 |
| 4 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.83791500 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.82373182 |
| 6 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.80264440 |
| 7 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.76556305 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.71475640 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.62313625 |
| 10 | * Amphetamine addiction_Homo sapiens_hsa05031 | 2.52833877 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.32576946 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.21645492 |
| 13 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.12027395 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.97614364 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.95976082 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.94776752 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.93856913 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89189142 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.80689244 |
| 20 | * Long-term depression_Homo sapiens_hsa04730 | 1.74303775 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.72310906 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.71889319 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.67844830 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62372618 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.57688706 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.51604421 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49705290 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.43648599 |
| 29 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.33253197 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.30119193 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29156788 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24805782 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.24434623 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23788011 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19095075 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14696661 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14153934 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.12070936 |
| 39 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.09338342 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.08471676 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08262727 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 1.02821985 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.98317522 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98226044 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95467670 |
| 46 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95433782 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.94030161 |
| 48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86030691 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.85586489 |
| 50 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85501209 |
| 51 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84889570 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83777628 |
| 53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82870582 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82173324 |
| 55 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.81704874 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.76292090 |
| 57 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74336303 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73513364 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73240585 |
| 60 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.72373048 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71884106 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 0.68325853 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67365157 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65413345 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65218099 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63278738 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61890956 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60394670 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59324317 |
| 70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58820951 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58771474 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56907837 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56084389 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55923434 |
| 75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55810173 |
| 76 | Tight junction_Homo sapiens_hsa04530 | 0.55132843 |
| 77 | Bile secretion_Homo sapiens_hsa04976 | 0.53531774 |
| 78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52945102 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50752957 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50397123 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49798031 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48620025 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46385984 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44510435 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43621358 |
| 86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42878526 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42734669 |
| 88 | Alcoholism_Homo sapiens_hsa05034 | 0.42532517 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40029830 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39863769 |
| 91 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39637736 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39634422 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39432508 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.38021134 |
| 95 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.37791007 |
| 96 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37787433 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37769091 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.37414143 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35357179 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33749881 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33080540 |
| 102 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31748408 |
| 103 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.31696687 |
| 104 | Melanoma_Homo sapiens_hsa05218 | 0.30781430 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30734646 |
| 106 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.30317776 |
| 107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29630879 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.29233902 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28921419 |
| 110 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.28394600 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.28143932 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27612116 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27487892 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.27287457 |
| 115 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.26885717 |
| 116 | Mineral absorption_Homo sapiens_hsa04978 | 0.25499297 |

